Experimental study of tetrodotoxin, a long-acting topical anesthetic

American Journal of Ophthalmology

Volumn 125, Issue 4, 1998, Pages 481-487

  Schwartz, Daniel M ^a   Fields, Howard L ^a   Duncan, Keith G ^a   Duncan, Jacque L ^a   Jones, Matthew R ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TETRODOTOXIN;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CORNEA; KERATECTOMY; NONHUMAN; POSTOPERATIVE PAIN; PRIORITY JOURNAL; RABBIT; TOPICAL ANESTHESIA; TOPICAL DRUG ADMINISTRATION;

EID: 0032052741     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9394(99)80188-3     Document Type: Article

References (24)

1. 1. Cherry PM. The treatment of pain following excimer laser photorefractive keratectomy: additive effect of local anesthetic drops, topical diclofenac, and bandage soft contact. J Cataract Refract Surg 1996;27(5,suppl):S477-S480.
2. 2. Verma S, Marshall J. Control of pain after photorefractive keratectomy. J Refract Surg 1996;12:358-364.
3. 3. Tutton MK, Cherry PM, Raj PS, Fsadni MG. Efficacy and safety of topical diclofenac in reducing ocular pain after excimer photorefractive keratectomy. J Cataract Refract Surg 1996;22:536-541.
4. 4. Smith RB, Everett WG. Physiology and pharmacology of local anesthetic agents. Int Ophthalmol Clin 1973; 13: 35-60.
5. 5. Behrendt T. Experimental study of corneal lesions: produced by topical anesthesia. Am J Ophthalmol 1956;41:99-105.
6. 6. Rosenwasser GOD. Complications of topical ocular anesthetics. Intl Ophthalmol Clin 1989;29:153-158.
7. 7. Rosenwasser GOD, Holland S, Pflugfelder SC, et al. Topical anesthetic abuse. Ophthalmology 1990;97:967-972.
8. 8. Bower DJ, Hart, RJ, Matthews PA, Howden ME. Nonprotein neurotoxins. Clin Toxicol 1981;18:813-863.
9. 9. Mills AR, Passmore R. Pelagic paralysis. Lancet 1988; 1:161-164.
10. 10. Kao CY. Tetrodotoxin, saxitoxin and their significance in the study of excitation phenomena. Pharm Review 1966;18: 997-1049.
11. 11. Tetrodotoxin poisoning associated with eating puffer fish transported from Japan-California. MMWR Morb Mortal Wkly Rep 1996;45:389-391.
12. 12. Lange WR. Puffer fish poisoning. Am Fam Physician 1990; 42:1029-1033.
13. 13. Mosher HS, Fuhrman A, Buchwald HD, Fischer HG. Tarichatoxin-tetrodotoxin: a potent neurotoxin. Science 1964;144:1100-1110.
14. 14. Blankenship JE. Tetrodotoxin: from poison to powerful tool. Perspect in Biol and Med 1976;19:509-526.
15. 15. Ogura Y, Mori Y. Mechanism of local anesthetic action of crystalline tetrodotoxin and its derivatives. Eur J Pharmacol 1968:3:58-67.
16. 16. Bynke G, Hakanson R, Sundler F. Is substance P necessary for corneal nociception? Eur J Pharmacol 1984;101:253-258.
17. 17. Maurice DM, Singh T. The absence of corneal toxicity with low-level topical anesthesia. Am J Ophthalmol 1985;99: 691-696.
18. 18. Ogura Y, Mori Y, Watanabe Y. Local anesthetic activity of crystalline tetrodotoxin and its related compounds. Folia Pharmacol 1966:Sect 20:62.
19. 19. Ogura Y, Hamada J, Tsukada O. Action of crystalline tetrodotoxin on nicotine and serotonin. Folia Pharmacol 1960;Sect 35:56.
20. 20. Kao CY, Fuhrman FA. Pharmacological studies on tarichatoxin, a potent neurotoxin. J Pharmacol 1963; 140:31-40.
21. 21. Spencer WH. Ophthalmic pathology, 3rd ed. Philadelphia: WB Saunders, 1985:235.
22. 22. Unger WG, Cole DF, Bass MS. Prostaglandin and neurogenically mediated ocular response to laser irradiation of the rabbit iris. Exp Eye Res 1977;25:209-220.
23. 23. Cornish JN. Susceptibility of man to puffer fish toxin. Austral 1973;2:48.
24. 24. Hamasaki K, Kogure K, Ohwada K. A biological method for the quantitative measurement of tetrodotoxin (TTX): tissue culture bioassay in combination with a water-soluble tetrazolium salt. Toxicon 1996:34:490-495.